Technical Analysis for XLRN - Acceleron Pharma Inc.

Grade Last Price % Change Price Change
D 118.18 -3.00% -3.65
XLRN closed down 3.0 percent on Friday, May 7, 2021, on 1.28 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.
Earnings due: May 10
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical XLRN trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Reversal New Lows Setup Bearish Swing Setup 0.00%
200 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Multiple of Ten Bearish Other 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Older End-of-Day Signals for XLRN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
200 DMA Support about 4 hours ago
Down 3% about 5 hours ago
Outside Day about 5 hours ago
Fell Below Previous Day's Low about 5 hours ago
60 Minute Opening Range Breakdown about 5 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. The company develops sotatercept and ACE-536 that are in Phase II clinical trials to treat anemia and associated complications in patients with ß-thalassemia and myelodysplastic syndromes (MDS), and red blood cell disorders; and dalantercept, which is in Phase II clinical trials to inhibit blood vessel formation in tumors through the vascular endothelial growth factor pathway inhibitors. It has collaboration, license, and option agreement with Celgene Corporation. The company, formerly known as Phoenix Pharma, Inc., was founded in 2003 and is headquartered in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Rare Diseases Tumors Anemia Myelodysplastic Syndrome Syndromes Red Blood Cell Myelodysplastic Syndromes Thalassemia Therapeutics For Cancer Vascular Endothelial Growth Factor

Is XLRN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 146.15
52 Week Low 85.58
Average Volume 367,467
200-Day Moving Average 117.55
50-Day Moving Average 129.71
20-Day Moving Average 122.87
10-Day Moving Average 123.48
Average True Range 4.59
ADX 16.26
+DI 12.95
-DI 21.91
Chandelier Exit (Long, 3 ATRs ) 120.64
Chandelier Exit (Short, 3 ATRs ) 131.16
Upper Bollinger Band 127.32
Lower Bollinger Band 118.42
Percent B (%b) -0.03
BandWidth 7.25
MACD Line -2.40
MACD Signal Line -2.23
MACD Histogram -0.1715
Fundamentals Value
Market Cap 7.12 Billion
Num Shares 60.3 Million
EPS -2.44
Price-to-Earnings (P/E) Ratio -48.43
Price-to-Sales 61.10
Price-to-Book 7.93
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 126.76
Resistance 3 (R3) 127.45 125.27 125.33
Resistance 2 (R2) 125.27 123.09 124.93 124.85
Resistance 1 (R1) 121.73 121.74 120.64 121.04 124.38
Pivot Point 119.55 119.55 119.01 119.21 119.55
Support 1 (S1) 116.01 117.37 114.92 115.32 111.98
Support 2 (S2) 113.83 116.02 113.49 111.51
Support 3 (S3) 110.29 113.83 111.03
Support 4 (S4) 109.60